166 related articles for article (PubMed ID: 38711107)
1. Association between retinal microvascular abnormalities and late-life brain amyloid-β deposition: the ARIC-PET study.
Egle M; Deal JA; Walker KA; Wong DF; Sharrett AR; Gottesman RF
Alzheimers Res Ther; 2024 May; 16(1):100. PubMed ID: 38711107
[TBL] [Abstract][Full Text] [Related]
2. Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.
Gottesman RF; Schneider AL; Zhou Y; Coresh J; Green E; Gupta N; Knopman DS; Mintz A; Rahmim A; Sharrett AR; Wagenknecht LE; Wong DF; Mosley TH
JAMA; 2017 Apr; 317(14):1443-1450. PubMed ID: 28399252
[TBL] [Abstract][Full Text] [Related]
3. Associations Between Mid-Life Psychosocial Measures and Estimated Late Life Amyloid Burden: The Atherosclerosis Risk in Communities (ARIC)-PET Study.
Groechel RC; Liu AC; Koton S; Kucharska-Newton AM; Lutsey PL; Mosley TH; Palta P; Sharrett AR; Walker KA; Wong DF; Gottesman RF
J Alzheimers Dis; 2024; 97(4):1901-1911. PubMed ID: 38339934
[TBL] [Abstract][Full Text] [Related]
4. Cognitive Reserve in Midlife is not Associated with Amyloid-β Deposition in Late-Life.
Rawlings AM; Sharrett AR; Mosley TH; Wong DF; Knopman DS; Gottesman RF
J Alzheimers Dis; 2019; 68(2):517-521. PubMed ID: 30775981
[TBL] [Abstract][Full Text] [Related]
5. Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.
Doraiswamy PM; Sperling RA; Coleman RE; Johnson KA; Reiman EM; Davis MD; Grundman M; Sabbagh MN; Sadowsky CH; Fleisher AS; Carpenter A; Clark CM; Joshi AD; Mintun MA; Skovronsky DM; Pontecorvo MJ;
Neurology; 2012 Oct; 79(16):1636-44. PubMed ID: 22786606
[TBL] [Abstract][Full Text] [Related]
6. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
7. Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.
Fleisher AS; Chen K; Liu X; Roontiva A; Thiyyagura P; Ayutyanont N; Joshi AD; Clark CM; Mintun MA; Pontecorvo MJ; Doraiswamy PM; Johnson KA; Skovronsky DM; Reiman EM
Arch Neurol; 2011 Nov; 68(11):1404-11. PubMed ID: 21747008
[TBL] [Abstract][Full Text] [Related]
8. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
[TBL] [Abstract][Full Text] [Related]
9. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.
Wu KY; Liu CY; Chen CS; Chen CH; Hsiao IT; Hsieh CJ; Lee CP; Yen TC; Lin KJ
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1067-76. PubMed ID: 26739329
[TBL] [Abstract][Full Text] [Related]
10. Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects.
Joshi AD; Pontecorvo MJ; Clark CM; Carpenter AP; Jennings DL; Sadowsky CH; Adler LP; Kovnat KD; Seibyl JP; Arora A; Saha K; Burns JD; Lowrey MJ; Mintun MA; Skovronsky DM;
J Nucl Med; 2012 Mar; 53(3):378-84. PubMed ID: 22331215
[TBL] [Abstract][Full Text] [Related]
11. Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease.
Edmonds EC; Bangen KJ; Delano-Wood L; Nation DA; Furst AJ; Salmon DP; Bondi MW;
J Int Neuropsychol Soc; 2016 Nov; 22(10):978-990. PubMed ID: 27903335
[TBL] [Abstract][Full Text] [Related]
12. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
[TBL] [Abstract][Full Text] [Related]
13. Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study.
Fleisher AS; Chen K; Quiroz YT; Jakimovich LJ; Gomez MG; Langois CM; Langbaum JB; Ayutyanont N; Roontiva A; Thiyyagura P; Lee W; Mo H; Lopez L; Moreno S; Acosta-Baena N; Giraldo M; Garcia G; Reiman RA; Huentelman MJ; Kosik KS; Tariot PN; Lopera F; Reiman EM
Lancet Neurol; 2012 Dec; 11(12):1057-65. PubMed ID: 23137949
[TBL] [Abstract][Full Text] [Related]
14. Relationship of Area of Soft Drusen in Retina with Cerebral Amyloid-β Accumulation and Blood Amyloid-β Level in the Elderly.
Shoda C; Kitagawa Y; Shimada H; Yuzawa M; Tateno A; Okubo Y
J Alzheimers Dis; 2018; 62(1):239-245. PubMed ID: 29439351
[TBL] [Abstract][Full Text] [Related]
15. Amyloid Deposition Is Greater in Cerebral Gyri than in Cerebral Sulci with Worsening Clinical Diagnosis Across the Alzheimer's Disease Spectrum.
Walden LM; Hu S; Madabhushi A; Prescott JW;
J Alzheimers Dis; 2021; 83(1):423-433. PubMed ID: 34334397
[TBL] [Abstract][Full Text] [Related]
16. Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI).
de Rojas I; Romero J; Rodríguez-Gomez O; Pesini P; Sanabria A; Pérez-Cordon A; Abdelnour C; Hernández I; Rosende-Roca M; Mauleón A; Vargas L; Alegret M; Espinosa A; Ortega G; Gil S; Guitart M; Gailhajanet A; Santos-Santos MA; Moreno-Grau S; Sotolongo-Grau O; Ruiz S; Montrreal L; Martín E; Pelejà E; Lomeña F; Campos F; Vivas A; Gómez-Chiari M; Tejero MA; Giménez J; Pérez-Grijalba V; Marquié GM; Monté-Rubio G; Valero S; Orellana A; Tárraga L; Sarasa M; Ruiz A; Boada M;
Alzheimers Res Ther; 2018 Nov; 10(1):119. PubMed ID: 30497535
[TBL] [Abstract][Full Text] [Related]
17. Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study.
van Arendonk J; Neitzel J; Steketee RME; van Assema DME; Vrooman HA; Segbers M; Ikram MA; Vernooij MW
Brain; 2023 Jan; 146(1):337-348. PubMed ID: 36374264
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal head-to-head comparison of
Chen CD; McCullough A; Gordon B; Joseph-Mathurin N; Flores S; McKay NS; Hobbs DA; Hornbeck R; Fagan AM; Cruchaga C; Goate AM; Perrin RJ; Wang G; Li Y; Shi X; Xiong C; Pontecorvo MJ; Klein G; Su Y; Klunk WE; Jack C; Koeppe R; Snider BJ; Berman SB; Roberson ED; Brosch J; Surti G; Jiménez-Velázquez IZ; Galasko D; Honig LS; Brooks WS; Clarnette R; Wallon D; Dubois B; Pariente J; Pasquier F; Sanchez-Valle R; Shcherbinin S; Higgins I; Tunali I; Masters CL; van Dyck CH; Masellis M; Hsiung R; Gauthier S; Salloway S; Clifford DB; Mills S; Supnet-Bell C; McDade E; Bateman RJ; Benzinger TLS;
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2669-2682. PubMed ID: 37017737
[TBL] [Abstract][Full Text] [Related]
19. Associations of Vascular Risk and Amyloid Burden with Subsequent Dementia.
Gottesman RF; Wu A; Coresh J; Knopman DS; Jack CR; Rahmim A; Sharrett AR; Spira AP; Wong DF; Wagenknecht LE; Hughes TM; Walker KA; Mosley TH
Ann Neurol; 2022 Oct; 92(4):607-619. PubMed ID: 35732594
[TBL] [Abstract][Full Text] [Related]
20. Associations Between Atrial Cardiopathy and Cerebral Amyloid: The ARIC-PET Study.
Johansen MC; Mosley TH; Knopman DS; Wong DF; Ndumele C; Shah AM; Solomon SD; Gottesman RF
J Am Heart Assoc; 2020 Dec; 9(24):e018399. PubMed ID: 33289449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
